Do randomized controlled trials always trump case reports? A second look at propranolol and depression

Pharmacotherapy

Volumn 26, Issue 2, 2006, Pages 162-167

  Steffensmeier, Jennifer J G ^a,b   Ernst, Michael E ^a,b   Kelly, Michael ^a,b   Hartz, Arthur J ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

adrenergic antagonist; blocker; Case reports; Depression; Evidence based medicine; Randomized controlled trials; RCTs; Research design

Indexed keywords

ANTIDEPRESSANT AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUCINDOLOL; LABETALOL; METOPROLOL; NADOLOL; PENBUTOLOL; PINDOLOL; PLACEBO; PROPRANOLOL; SOTALOL; TIMOLOL;

ACUTE HEART INFARCTION; BECK DEPRESSION INVENTORY; CASE REPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEPRESSION; EVIDENCE BASED MEDICINE; HEART FAILURE; HUMAN; HYPERTENSION; META ANALYSIS; METHODOLOGY; NARANJO SCORE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCORING SYSTEM; SIDE EFFECT; SYSTEMATIC REVIEW;

ADRENERGIC BETA-ANTAGONISTS; ADULT; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPRANOLOL; RANDOMIZED CONTROLLED TRIALS;

EID: 32044474215     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.26.2.162     Document Type: Review

References (40)

1. Waal H. Propranolol-induced depression [letter]. BMJ 1967;2:50.
2. Kohn R. Beta-blockers an important cause of depression: a medical myth without evidence. Med Health Rhode Island 2001;84:92-5.
3. Nemeroff C, Evans DL. Concurrent use of antidepressants and propranolol: case report and theoretical considerations. Biol Psychiatry 1983;18:237-41.
4. Jouvent R, Baruch P, Simon P. Manic episode after propranolol withdrawal [case report]. Am J Psychiatry 1986;143:1633.
5. Patterson J. Depression associated with enalapril. South Med J 1989;82:402-3.
6. Nolan B. Acute suicidal depression associated with use of timolol [case report]. JAMA 1982;247:1567.
7. Rao MR, O'Brien J, Dening TR, Dober M. Systemic hazards of ocular timolol [case report]. Br J Hosp Med 1993;50:553.
8. Kurtz S, Ashkenazi I, Melamed S. Major depressive episode secondary to antiglaucoma drugs. Am J Psychiatry 1993;150:524-5.
9. Russell J, Schuckit MA. Anxiety and depression in patient on nadolol. Lancet 1982;2(8310):1286-7.
10. Kantor S. Transference and the beta adrenergic receptor: a case presentation. Psychiatry 1989;52:107-15.
11. Walley T, Proudlove C, Maxwell D. Interaction of metoprolol and fluoxetine. Lancet 1993;341:967-8.
12. Thiessen B, Wallace SM, Blackburn JL, Wilson TW, Bergman U. Increased prescribing of antidepressants subsequent to β-blocker therapy. Arch Intern Med 1990;150:2286-90.
13. Avorn J, Everitt DE, Weiss S. Increased antidepressant use in patients prescribed β-blockers. JAMA 1986;255:357-60.
14. Medical Economics Company. Propranolol: Inderal LA. In: Physicians' desk reference. 58th ed. Montvale, NJ: Thomson Healthcare, 2004:3430-1.
15. Facts and Comparisons. Beta-adrenergic blocking agents. In: Drug facts and comparisons. 57th ed. St. Louis, MO: Facts and Comparisons, 2002:504-10.
16. Wood A. Adverse reactions to drugs. In: Braunwald E, ed. Harrison's principles of internal medicine. 15th ed. New York, NY: McGraw-Hill Professional; 2001:436.
17. Eisendrath S, Lichtmacher JE. Psychiatric disorders. In: Tierney L, ed. Current medical diagnosis and treatment. 43rd ed. New York, NY: McGraw-Hill, 2004:1030-1.
18. Griffin SJ, Friedman MJ. Depressive symptoms in propranolol users. J Clin Psychiatry 1986;47:453-7.
19. Oppenheim G. Propranolol-induced depression: mechanism and management. Aust N Z J Psychiatry 1983;17:400-2.
20. Ko D, Herbert PR, Coffey CS, Sedrakyan A, Curtis JP, Krumholz HM. β-Blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 2002;288:351-7.
21. Naranjo C, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
22. Michel D, Knodel LC. Comparison of three algorithms used to evaluate adverse drug reactions. Am J Hosp Pharm 1986;43:1709-14.
23. Cremona-Barbaro A. Propranolol and depression [case report]. Lancet 1983;8317:185.
24. Petrie W, Maffucci RJ, Woosley RL. Propranolol and depression. Am J Psychiatry 1982;139:92-4.
25. Parker W. Propranolol-induced depression and psychosis. Clin Pharmacol Ther 1985;4:214-18.
26. Pollack M, Rosenbaum JF, Cassem NH. Propranolol and depression revisited: three cases and a review. J Nerv Ment Dis 1985;173:118-19.
27. McNeil G, Shaw PK, Dock DS. Substitution of atenolol for propranolol in a case of propranolol-related depression. Am J Psychiatry 1982;139:1187-8.
28. Kalayam B, Shamoian CA. Propranolol, psychoneuroendocrine changes, and depression. Am J Psychiatry 1982;139:1374-5.
29. Segal A. Prophylaxis of supraventricular tachycardia [case report]. BMJ 1971;4:559.
30. Hansteen V, Moinichen E, Lorentsen E, et al. One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. BMJ 1982;284:155-60.
31. Beta Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. JAMA 1982;247:1707-14.
32. Pérez-Stable E, Gardiner PS, Baron RB, Hauck WW, Acree M, Coates TJ. The effects of propranolol on cognitive function and quality of life: a randomized trial among patients with diastolic hypertension. Am J Med 2000;108:359-65.
33. Julian D, Prescott RJ, Jackson FS, Szekely P. Controlled trial of sotalol for one year after myocardial infarction. Lancet 1982;1:1142-7.
34. Coope J, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. BMJ 1986;293:1145-51.
35. Dahlöf B, Lindholm LH, Hansson L, Schrstén B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-hypertension). Lancet 1991;338:1281-5.
36. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-55.
37. Beta Blocker Evaluation of Survival Trial Investigators. A trial of the beta blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med 2001;344:1659-67.
38. Beta Blocker Heart Attack Trial Research Group. Beta blocker heart attack trial: design features. Control Clin Trials 1981;2:275-85.
39. Ekbom T, Dahlöf B, Hansson L, Lindholm LH, Scherstén B, Wester PO. Antihypertensive efficacy and adverse effects of three beta-blockers and a diuretic in elderly hypertensives: a report from the STOP-hypertensive study. J Hyperten 1992;10:1525-30.
40. Etminan M, Carleton B, Rochon PA. Quantifying adverse drug events: are systematic reviews the answer? Drug Saf 2004;27(11):757-61.